Syndax Pharmaceuticals (SNDX) Asset Utilization Ratio (2016 - 2026)

Syndax Pharmaceuticals' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.43 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 577.44% year-over-year to 0.43; the TTM figure through Mar 2026 stood at 0.43 (up 577.44% YoY), while the FY2025 annual figure was 0.27, up 676.09% from the prior year.
• Asset Utilization Ratio was 0.43 for Q1 2026 at Syndax Pharmaceuticals, up from 0.32 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q1 2026 to a low of 0.01 in Q2 2024.
• Historically, Asset Utilization Ratio has averaged 0.19 across 4 years, with a median of 0.19 in 2025.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio plunged 97.81% in 2024, then soared 1742.04% in 2025.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.25 in 2023, then plunged by 83.54% to 0.04 in 2024, then surged by 675.47% to 0.32 in 2025, then soared by 35.91% to 0.43 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.43 (Q1 2026), 0.32 (Q4 2025), and 0.19 (Q3 2025), per Business Quant data.